🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Phoenix
Start Date
2017-03-27
Trial ID
NCT03062540
Treatments Being Tested
The purpose of this study is to see whether the combination of a muscle rel...
Status
Completed
Location
Stony Brook University
Start Date
2003-01
Trial ID
NCT00790270
Treatments Being Tested
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Ashild Peters
Start Date
2019-03-07
Trial ID
NCT03841773
Treatments Being Tested
Very low dose (VLD) cyclobenzaprine at bedtime has shown promise as a treat...
Status
Completed
Location
PharmaNet, Inc.
Start Date
2013-06
Trial ID
NCT01889173
Many women with breast cancer who are treated with aromatase inhibitor medi...
Status
Terminated
Location
University of Michigan Comprehensive Cancer Center
Start Date
2013-08
Trial ID
NCT01921296
Treatments Being Tested
This study examines the effect of electromyography biofeedback on masticato...
Status
Not Yet Recruiting
Location
Misr University for Science and Technology
Start Date
2025-03-26
Trial ID
NCT06894472
Treatments Being Tested
The primary objective of the study is to evaluate the effectiveness and saf...
Status
Terminated
Location
The Headache Center at Kennedy Health Alliance
Start Date
2010-07
Trial ID
NCT01151787
Treatments Being Tested
This is a Phase 3, open-label, extension trial designed to evaluate the lon...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-04
Trial ID
NCT02589275
Treatments Being Tested
The purpose of this study is to determine if a stepped-care intervention ma...
Status
Completed
Location
Richard Roudebush VA Medical Center, Indianapolis
Start Date
2007-12
Trial ID
NCT00386243
TNX-102 SL has recently been approved by the United States (US) Food and Dr...
Status
Active Not Recruiting
Location
Syneos Health Clinique, Inc.
Start Date
2025-12-09
Trial ID
NCT07413367
Treatments Being Tested